Literature DB >> 15211434

The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study.

Joshua I Barzilay1, Do Peterson, Mary Cushman, Susan R Heckbert, Jie J Cao, Caroline Blaum, Russell P Tracy, Ronald Klein, David M Herrington.   

Abstract

BACKGROUND: Microalbuminuria is a risk factor for coronary heart disease (CHD). It occurs most commonly in the settings of diabetes and hypertension. The mechanisms by which it increases CHD risk are uncertain.
METHODS: We examined the cross-sectional association of microalbuminuria with a broad range of CHD risk factors in 3 groups of adults aged 65 years or older with and without microalbuminuria: those with (1) no diabetes or hypertension (n = 1,098), (2) hypertension only (n = 1,450), and (3) diabetes with or without hypertension (n = 465).
RESULTS: Three factors were related to microalbuminuria in all 3 groups: age, elevated systolic blood pressure, and markers of systemic inflammation. In patients with neither diabetes nor hypertension, increasing C-reactive protein levels were associated with microalbuminuria (odds ratio per 1-mg/L increase, 1.46; 95% confidence interval [CI], 1.15 to 1.84). Among those with diabetes, an increase in white blood cell (WBC) count was associated with microalbuminuria (odds ratio per 1,000-cell/mL increase, 2.57; 95% CI, 1.12 to 5.89). Among those with hypertension, an increase in WBC count (odds ratio per 1,000-cell/mL increase, 1.83; 95% CI, 1.04 to 3.23) and fibrinogen level (odds ratio per 10-mg/dL increase, 1.02; 95% CI, 1.00 to 1.05) were significantly associated with microalbuminuria. In all 3 groups, prevalent CHD was related to an elevated WBC count. In none of the 3 groups was brachial artery reactivity to ischemia, an in vivo marker of endothelial function, related to microalbuminuria.
CONCLUSION: Microalbuminuria is associated with age, systolic blood pressure, and markers of inflammation. These associations reflect potential mechanisms by which microalbuminuria is related to CHD risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211434     DOI: 10.1053/j.ajkd.2004.03.022

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  33 in total

1.  Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study.

Authors:  C A Geluk; R A Tio; J G P Tijssen; R B van Dijk; W A Dijk; H L Hillege; P E de Jong; W H van Gilst; F Zijlstra
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

2.  Associations between microalbuminuria and animal foods, plant foods, and dietary patterns in the Multiethnic Study of Atherosclerosis.

Authors:  Jennifer A Nettleton; Lyn M Steffen; Walter Palmas; Gregory L Burke; David R Jacobs
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

3.  Ratio of urine albumin to creatinine attenuates the association of dementia with hip fracture risk.

Authors:  Petra Bůžková; Joshua I Barzilay; Howard A Fink; John A Robbins; Jane A Cauley; Annette L Fitzpatrick
Journal:  J Clin Endocrinol Metab       Date:  2014-08-22       Impact factor: 5.958

4.  Albuminuria and the risk of incident stroke and stroke types in older adults.

Authors:  M I Aguilar; E S O'Meara; S Seliger; W T Longstreth; R G Hart; P E Pergola; M G Shlipak; R Katz; M J Sarnak; D E Rifkin
Journal:  Neurology       Date:  2010-09-01       Impact factor: 9.910

Review 5.  Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.

Authors:  Pranav S Garimella; Alan T Hirsch
Journal:  Adv Chronic Kidney Dis       Date:  2014-10-24       Impact factor: 3.620

Review 6.  Cognitive Impairment and Dementia in Older Adults With Chronic Kidney Disease: A Review.

Authors:  Andrea R Zammit; Mindy J Katz; Markus Bitzer; Richard B Lipton
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Oct-Dec       Impact factor: 2.703

7.  Albuminuria is associated with hip fracture risk in older adults: the cardiovascular health study.

Authors:  J I Barzilay; P Bůžková; Z Chen; I H de Boer; L Carbone; N N Rassouli; H A Fink; J A Robbins
Journal:  Osteoporos Int       Date:  2013-05-24       Impact factor: 4.507

Review 8.  Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.

Authors:  Seiji Ueda; Sho-Ichi Yamagishi; Yuriko Matsumoto; Kei Fukami; Seiya Okuda
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

9.  Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

Authors:  Mohamed E Suliman; Mahmut I Yilmaz; Juan J Carrero; Abdul Rashid Qureshi; Mutlu Saglam; Osman M Ipcioglu; Mujdat Yenicesu; Mengli Tong; Olof Heimbürger; Peter Barany; Anders Alvestrand; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 8.237

10.  Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study.

Authors:  David J Leehey; Irfan Moinuddin; Joseph P Bast; Shahzad Qureshi; Christine S Jelinek; Cheryl Cooper; Lonnie C Edwards; Bridget M Smith; Eileen G Collins
Journal:  Cardiovasc Diabetol       Date:  2009-12-09       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.